![Mark Lerner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mr. Mark D.
Lerner was previously employed as a Non-Executive Director by Gliknik, Inc. and a Vice President by Chesapeake Partners Management Co., Inc. He received his undergraduate degree from the University of Pennsylvania and an undergraduate degree from The Wharton School of the University of Pennsylvania.
| Unternehmen | Position | Ende |
|---|---|---|
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biotechnology drugs for autoimmune diseases and cancer | Direktor/Vorstandsmitglied | - |
Chesapeake Partners Management Co., Inc.
 Chesapeake Partners Management Co., Inc. Investment ManagersFinance Chesapeake Partners Management Co. manages investment funds that seek to achieve above-average returns through “event specific” investing with a value overlay. This includes investments in issuers which are engaged in or undergoing extraordinary events, such as mergers, acquisitions, recapitalizations, liquidations or other corporate restructuring transactions where there is a perceived differential between the value to be received upon successful consummation of the anticipated transaction or event and the current market price. Other investment opportunities are found in the securities of companies undergoing extraordinary events such as regulatory approval processes, management changes, litigation situations, industry-specific transformations, as well as those emanating from a range of macroeconomic occurrences. The funds invest in a broad range of securities and other instruments, including equities, equity-related securities, bonds, other fixed income securities, options, futures, other derivatives and currencies. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Chesapeake Partners Management Co., Inc.
Chesapeake Partners Management Co., Inc. Investment ManagersFinance Chesapeake Partners Management Co. manages investment funds that seek to achieve above-average returns through “event specific” investing with a value overlay. This includes investments in issuers which are engaged in or undergoing extraordinary events, such as mergers, acquisitions, recapitalizations, liquidations or other corporate restructuring transactions where there is a perceived differential between the value to be received upon successful consummation of the anticipated transaction or event and the current market price. Other investment opportunities are found in the securities of companies undergoing extraordinary events such as regulatory approval processes, management changes, litigation situations, industry-specific transformations, as well as those emanating from a range of macroeconomic occurrences. The funds invest in a broad range of securities and other instruments, including equities, equity-related securities, bonds, other fixed income securities, options, futures, other derivatives and currencies. | Finance |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biotechnology drugs for autoimmune diseases and cancer | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
